Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis.
about
Newborn screening for cystic fibrosisEarly anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'Impact of multidrug-resistant organisms on patients considered for lung transplantation.Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic FibrosisEarly immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosisPseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: assessment of clinic exposures and microbial genotypesEffect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study.Management of refractory Pseudomonas aeruginosa infection in cystic fibrosisChest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis.Infection control in cystic fibrosis.The sensitivity of lung disease surrogates in detecting chest CT abnormalities in children with cystic fibrosis.Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis.Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort.Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosisPredictors of mucoid Pseudomonas colonization in cystic fibrosis patientsStaphylococcus aureus Protein A Mediates Interspecies Interactions at the Cell Surface of Pseudomonas aeruginosa.Risk factors for the progression of cystic fibrosis lung disease throughout childhood.Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients.Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas.Chronic infection phenotypes of Pseudomonas aeruginosa are associated with failure of eradication in children with cystic fibrosis.Differential geographical risk of initial Pseudomonas aeruginosa acquisition in young US children with cystic fibrosis.Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis.Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.Lung colonization with Aeromonas hydrophila in cystic fibrosis believed to have come from a tropical fish tank.Newborn screening for cystic fibrosis
P2860
Q24241094-3CA8C36C-6FA6-4927-9827-EC7B018E8B67Q30436229-450F47D7-1570-45EE-A3E7-EF1141970BE4Q33576059-D9602EC1-5786-4F5E-BC27-604B2087DD27Q33783497-7B6CBBF0-06F1-408D-AF54-B581B390C76BQ34041909-3A0BC1A0-2E94-4D25-A534-E6191B24536EQ34067203-5EF14369-98AF-4F1C-ACDC-17B13230825AQ34085781-73EB4E97-2733-44C6-B241-F7CB006A7B60Q35026630-3B27208A-E6FB-4E6C-8AEF-7F42C890B32DQ35528367-C14D9C06-08D2-45B0-83FF-13CF59233F1EQ35545544-474CF55C-5BD3-4B01-AF5C-81E5B1E94BDBQ35842898-5CC5AB1D-EB9B-466D-BDC5-8A8DC47456B8Q36050609-EE0F6B50-7E0E-483B-AADE-C598CFDAA84FQ36673569-78A02E5B-AD0F-451E-A696-6FCCEC2EBE05Q36929794-61B62049-A02B-4BDF-B23B-40562C6717B8Q36956804-29C9928F-DFA3-41E5-8B16-9BD2A16FCFC9Q36974210-380E0C5B-49E1-4975-8818-1DE07AA92AB3Q37679783-5C863F2A-7DAB-44CF-A688-BFC175387036Q38769187-2181939A-67CE-44E3-985A-B63035D51E51Q40749683-D4D9424D-18CD-4342-9311-55B779462500Q40940721-ADDE6C61-153E-4DA4-BD79-E8F3221B3F6EQ44656924-C54D46DF-4001-436D-8178-112184FED191Q47692118-2F102C30-314D-43E9-A93C-93FF4F87F836Q51656199-07BA7A01-3A34-4017-A6B4-6A3A54020A1AQ55663577-8B3F3591-97A8-4B03-8477-D338C78CB76EQ57692746-0E739DC7-E6A8-47F9-9B08-0E528C04A0CF
P2860
Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Comprehensive analysis of risk ...... children with cystic fibrosis.
@en
Comprehensive analysis of risk ...... children with cystic fibrosis.
@nl
type
label
Comprehensive analysis of risk ...... children with cystic fibrosis.
@en
Comprehensive analysis of risk ...... children with cystic fibrosis.
@nl
prefLabel
Comprehensive analysis of risk ...... children with cystic fibrosis.
@en
Comprehensive analysis of risk ...... children with cystic fibrosis.
@nl
P2093
P2860
P1476
Comprehensive analysis of risk ...... children with cystic fibrosis.
@en
P2093
Farrell PM
Jalaluddin M
Kosorok MR
Splaingard M
P2860
P356
10.1002/(SICI)1099-0496(199808)26:2<81::AID-PPUL2>3.0.CO;2-K
P577
1998-08-01T00:00:00Z